ArticleVirology journal2022

A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy.

Han Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.